Mark Kong CFA
Stock Analyst at DBS
(1.48)
# 3,638
Out of 4,792 analysts
7
Total ratings
47.1%
Success rate
-0.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mark Kong CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1093 CSPC Pharmaceutical Group Limited | Initiated Coverage: Buy | $13.70 | $8.77 | +56.21% | 1 | Sep 10, 2026 | |
| HKG: 6160 BeOne Medicines AG | Reiterated: Hold | $290.00 | $207.00 | +40.10% | 4 | Sep 7, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $144.00 | $94.35 | +52.62% | 2 | Aug 26, 2026 |
CSPC Pharmaceutical Group Limited
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $13.70
Current: $8.77
Upside: +56.21%
BeOne Medicines AG
Sep 7, 2026
Reiterated: Hold
Price Target: $290.00
Current: $207.00
Upside: +40.10%
Innovent Biologics, Inc.
Aug 26, 2026
Reiterated: Buy
Price Target: $144.00
Current: $94.35
Upside: +52.62%